{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:52:50Z","timestamp":1793145170509,"version":"4.5.0"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005668","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Distrito Federal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Pesquisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.pharmthera.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T02:43:49Z","timestamp":1540003429000},"page":"21-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"special_numbering":"C","title":["Antifungal drugs: New insights in research &amp; development"],"prefix":"10.1016","volume":"195","author":[{"given":"Andr\u00e9 Moraes","family":"Nicola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo Costa","family":"Paes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabricio F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Seki","family":"Kioshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Karina Rodrigues","family":"Abadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anam\u00e9lia Lorenzetti","family":"Bocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sueli","family":"Felipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2018.10.008_bb0005","first-page":"12","article-title":"Comparative genomics allowed the identification of drug targets against human fungal pathogens","author":"Abadio","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142926","article-title":"Identification of new antifungal compounds targeting thioredoxin reductase of Paracoccidioides Genus","volume":"10","author":"Abadio","year":"2015","journal-title":"PLOS One"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0015","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/AAC.37.12.2628","article-title":"Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro","volume":"37","author":"Alcouloumre","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1128\/AAC.48.1.41-47.2004","article-title":"Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans","volume":"48","author":"Alem","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/clim.2002.5207","article-title":"Interleukin-12 Protects Mice against Disseminated Infection Caused by Paracoccidioides brasiliensis but Enhances Pulmonary Inflammation","volume":"103","author":"Arruda","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120201","article-title":"Saccharomyces cerevisiae Expressing Gp43 Protects Mice against Paracoccidioides brasiliensis Infection","volume":"10","author":"Assis-Marques","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0035","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1021\/ol5037248","article-title":"Mohangamides A and B, New Dilactone-Tethered Pseudo-Dimeric Peptides Inhibiting Candida albicans Isocitrate Lyase","volume":"17","author":"Bae","year":"2015","journal-title":"Organic Lett."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0040","doi-asserted-by":"crossref","first-page":"e00165","DOI":"10.1128\/AAC.00165-17","article-title":"Targeting the Homoserine Dehydrogenase of Paracoccidioides Species for Treatment of Systemic Fungal Infections","volume":"61","author":"Bagatin","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0045","doi-asserted-by":"crossref","first-page":"e00831","DOI":"10.1128\/mBio.00831-16","article-title":"A Class 1 Histone Deacetylase with Potential as an Antifungal Target","volume":"7","author":"Bauer","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0050","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1021\/cb100399x","article-title":"Identification, in Vitro Activity and Mode of Action of Phosphoinositide-Dependent-1 Kinase Inhibitors as Antifungal Molecules","volume":"6","author":"Baxter","year":"2011","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0055","doi-asserted-by":"crossref","first-page":"22044","DOI":"10.1073\/pnas.1009845107","article-title":"Pathway analysis of Candida albicans survival and virulence determinants in a murine infection model","volume":"107","author":"Becker","year":"2010","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1097-0282(2000)55:1<74::AID-BIP70>3.0.CO;2-S","article-title":"Combinatorial libraries: A tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies","volume":"55","author":"Blondelle","year":"2000","journal-title":"Biopolymers"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.00311","article-title":"\u039424-Sterol Methyltransferase Plays an Important Role in the Growth and Development of Sporothrix schenckii and Sporothrix brasiliensis","volume":"7","author":"Borba-Santos","year":"2016","journal-title":"Frontiers in Microbiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2018.10.008_bb0070","article-title":"Post-Genomic Analysis of Members of the Family Vibrionaceae","volume":"3","author":"Boyd","year":"2015","journal-title":"Microbiological Spectrum"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0075","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1128\/IAI.01470-08","article-title":"Paracoccidioides brasiliensis Vaccine Formulations Based on the gp43-Derived P10 Sequence and the Salmonella enterica FliC Flagellin","volume":"77","author":"Braga","year":"2009","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0080","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1080\/21505594.2015.1038014","article-title":"Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes","volume":"6","author":"Brand\u00e3o","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-21965-y","article-title":"HDAC genes play distinct and redundant roles in Cryptococcus neoformans virulence","volume":"8","author":"Brand\u00e3o","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coi.2005.11.004","article-title":"Cationic host defense (antimicrobial) peptides","volume":"18","author":"Brown","year":"2006","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0095","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1128\/IAI.00349-08","article-title":"The Monoclonal Antibody against the Major Diagnostic Antigen of Paracoccidioides brasiliensis Mediates Immune Protection in Infected BALB\/c Mice Challenged Intratracheally with the Fungus","volume":"76","author":"Buissa-Filho","year":"2008","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/21505594.2016.1216283","article-title":"Antifungal adjuvants: Preserving and extending the antifungal arsenal","volume":"8","author":"Butts","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0105","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1467-7652.2010.00586.x","article-title":"Plant production of anti-\u03b2-glucan antibodies for immunotherapy of fungal infections in humans: Plant antibodies for human antifungal therapy","volume":"9","author":"Capodicasa","year":"2011","journal-title":"Plant Biotechnology Journal"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0110","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1002\/bit.26403","article-title":"Comparative analysis of plant-produced, recombinant dimeric IgA against cell wall \u03b2-glucan of pathogenic fungi","volume":"114","author":"Capodicasa","year":"2017","journal-title":"Biotechnology and Bioengineering"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0115","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/EC.00324-09","article-title":"The Transposon impala Is Activated by Low Temperatures: Use of a Controlled Transposition System To Identify Genes Critical for Viability of Aspergillus fumigatus","volume":"9","author":"Carr","year":"2010","journal-title":"Eukaryotic Cell"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0120","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chom.2012.04.004","article-title":"Immunoglobulins in Defense, Pathogenesis, and Therapy of Fungal Diseases","volume":"11","author":"Casadevall","year":"2012","journal-title":"Cell Host & Microbe"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1084\/jem.174.1.151","article-title":"The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies","volume":"174","author":"Casadevall","year":"1991","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0130","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/infdis\/165.6.1086","article-title":"Antibodies Elicited by a Cryptococcus neoformans -Tetanus Toxoid Conjugate Vaccine Have the Same Specificity as Those Elicited in Infection","volume":"165","author":"Casadevall","year":"1992","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0135","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00204-016-1916-3","article-title":"New developments and directions in the clinical application of the echinocandins","volume":"91","author":"Chang","year":"2017","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0140","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1128\/CDLI.12.9.1063-1068.2005","article-title":"Monoclonal Immunoglobulin G1 Directed against Aspergillus fumigatus Cell Wall Glycoprotein Protects against Experimental Murine Aspergillosis","volume":"12","author":"Chaturvedi","year":"2005","journal-title":"Clinical and Vaccine Immunology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0145","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1128\/IAI.00834-08","article-title":"Two-Component Signal Transduction Proteins as Potential Drug Targets in Medically Important Fungi","volume":"76","author":"Chauhan","year":"2008","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095951","article-title":"Inhibitors of the Glyoxylate Cycle Enzyme ICL1 in Candida albicans for Potential Use as Antifungal Agents","volume":"9","author":"Cheah","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0155","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4155\/fmc-2016-0035","article-title":"Natural and synthetic peptides with antifungal activity","volume":"8","author":"Ciociola","year":"2016","journal-title":"Future Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0160","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1099\/jmm.0.079681-0","article-title":"Whole glucan particles as a vaccine against murine aspergillosis","volume":"63","author":"Clemons","year":"2014","journal-title":"Journal of Medical Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0165","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1099\/jmm.0.000138","article-title":"Whole glucan particles as a vaccine against systemic coccidioidomycosis","volume":"64","author":"Clemons","year":"2015","journal-title":"J Med Microbiol."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0170","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/AAC.05056-14","article-title":"Ibuprofen Potentiates the In Vivo Antifungal Activity of Fluconazole against Candida albicans Murine Infection","volume":"59","author":"Costa-de-Oliveira","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0175","doi-asserted-by":"crossref","first-page":"a019752","DOI":"10.1101\/cshperspect.a019752","article-title":"Mechanisms of Antifungal Drug Resistance","volume":"5","author":"Cowen","year":"2015","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0180","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.bpj.2016.08.032","article-title":"Mode of Action of a Designed Antimicrobial Peptide: High Potency against Cryptococcus neoformans","volume":"111","author":"Datta","year":"2016","journal-title":"Biophysical Journal"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0185","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1128\/AAC.01654-13","article-title":"Synthesis and Antifungal Activity In Vitro of Isoniazid Derivatives against Histoplasma capsulatum var. capsulatum","volume":"58","author":"de Aguiar Cordeiro","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0190","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.tim.2003.08.008","article-title":"Progress in functional genomics approaches to antifungal drug target discovery","volume":"11","author":"De Backer","year":"2003","journal-title":"Trends in Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0195","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/85677","article-title":"An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans","volume":"19","author":"De Backer","year":"2001","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0200","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jinf.2013.07.019","article-title":"Characterization of the immune response in human paracoccidioidomycosis","volume":"67","author":"de Castro","year":"2013","journal-title":"Journal of Infection"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.43.1.1","article-title":"Antifungal peptides: novel therapeutic compounds against emerging pathogens","volume":"43","author":"De Lucca","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020012","article-title":"Design, Synthesis, and Characterization of a Highly Effective Hog1 Inhibitor: A Powerful Tool for Analyzing MAP Kinase Signaling in Yeast","volume":"6","author":"Din\u00e9r","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0215","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/infdis\/163.5.1114","article-title":"Improved Amphotericin B Activity by a Monoclonal Anti-Cryptococcus neoformans Antibody: Study during Murine Cryptococcosis and Mechanisms of Action","volume":"163","author":"Dromer","year":"1991","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0220","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1128\/iai.55.3.749-752.1987","article-title":"Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody","volume":"55","author":"Dromer","year":"1987","journal-title":"Infectious Immunology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0225","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/iai.55.3.742-748.1987","article-title":"Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide","volume":"55","author":"Dromer","year":"1987","journal-title":"Infectious Immunology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0230","first-page":"8","article-title":"Effect of the Novel Antifungal Drug F901318 (Olorofim) on Growth and Viability of Aspergillus fumigatus","volume":"62","author":"Du","year":"2018","journal-title":"Antimicrobial Agents Chemotherapy."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0235","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fbr.2012.11.001","article-title":"Commercialization of antifungal peptides","volume":"26","author":"Duncan","year":"2013","journal-title":"Fungal Biology Reviews"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0240","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1099\/mic.0.030858-0","article-title":"Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis","volume":"155","author":"Dunn","year":"2009","journal-title":"Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0245","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1128\/iai.55.8.1895-1899.1987","article-title":"Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide","volume":"55","author":"Eckert","year":"1987","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0250","first-page":"18","article-title":"Prediction of essential proteins based on subcellular localization and gene expression correlation","author":"Fan","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0255","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/mmi.12290","article-title":"Genetic and structural validation of Aspergillus fumigatus UDP- N -acetylglucosamine pyrophosphorylase as an antifungal target: Structural and genetic validation of Af UAP1","volume":"89","author":"Fang","year":"2013","journal-title":"Molecular Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0260","doi-asserted-by":"crossref","first-page":"24706","DOI":"10.1074\/jbc.M500625200","article-title":"Transcriptional Profiles of the Human Pathogenic Fungus Paracoccidioides brasiliensis in Mycelium and Yeast Cells","volume":"280","author":"Felipe","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0265","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.drudis.2016.06.021","article-title":"Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective","volume":"21","author":"Ferreira","year":"2016","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0270","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5495\/wjcid.v1.i1.4","article-title":"Statins as antifungal agents","volume":"1","author":"Galg\u00f3czy","year":"2011","journal-title":"World Journal of Clinical Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0275","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/AAC.01677-13","article-title":"Novel Antifungal Drug Discovery Based on Targeting Pathways Regulating the Fungus-Conserved Upc2 Transcription Factor","volume":"58","author":"Gallo-Ebert","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0280","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/BF00205029","article-title":"Isolation and physico-chemical characterization of an antifungal and antibacterial peptide produced by Bacillus licheniformis A12","volume":"39","author":"G\u00e1lvez","year":"1993","journal-title":"Applied Microbiology and Biotechnology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0285","doi-asserted-by":"crossref","first-page":"e00244","DOI":"10.1128\/AAC.00244-18","article-title":"Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis","volume":"62","author":"Ghannoum","year":"2018","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0290","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3109\/14756366.2016.1156103","article-title":"Identification of new anti- Candida compounds by ligand-based pharmacophore virtual screening","volume":"31","author":"Gidaro","year":"2016","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/s11535-007-0010-5","article-title":"Antimicrobial peptides: an overview of a promising class of therapeutics","volume":"2","author":"Giuliani","year":"2007","journal-title":"Open Life Sciences"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0300","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1007\/s00253-015-7223-8","article-title":"Structural and functional characterization of the recombinant thioredoxin reductase from Candida albicans as a potential target for vaccine and drug design","volume":"100","author":"Godoy","year":"2016","journal-title":"Applied Microbiology and Biotechnology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0305","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3390\/molecules23030599","article-title":"Synthesis, Molecular Docking, and Antimycotic Evaluation of Some 3-Acyl Imidazo[1,2-a]pyrimidines","volume":"23","author":"G\u00f3mez-Garc\u00eda","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0310","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02713680590968637","article-title":"A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs","volume":"30","author":"Gordon","year":"2005","journal-title":"Current Eye Research"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0315","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.FUNK-0035-2016","article-title":"The Fungal Cell Wall: Structure, Biosynthesis, and Function","volume":"5","author":"Gow","year":"2017","journal-title":"Microbiology Spectrum"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0320","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2174\/1568026616666160713143331","article-title":"Antimicrobial Peptides Under Clinical Trials","volume":"17","author":"Greber","year":"2017","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081907","article-title":"Fingolimod (FTY720) Stimulates Ca2+\/Calcineurin Signaling in Fission Yeast","volume":"8","author":"Hagihara","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0330","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/13693780903390208","article-title":"Inhibition of ergosterol synthesis by novel antifungal compounds targeting C-14 reductase","volume":"48","author":"Hata","year":"2010","journal-title":"Medical Mycology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0335","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1248\/bpb.33.473","article-title":"In Vitro and in Vivo Antifungal Activities of Aminopiperidine Derivatives, Novel Ergosterol Synthesis Inhibitors","volume":"33","author":"Hata","year":"2010","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0340","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1016\/j.bmcl.2012.05.031","article-title":"Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of \u03b2-1,3-glucan synthase","volume":"22","author":"Heasley","year":"2012","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0345","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/AAC.34.4.587","article-title":"Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis","volume":"34","author":"Hector","year":"1990","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0350","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.fbr.2012.07.002","article-title":"Antifungal proteins: More than antimicrobials?","volume":"26","author":"Heged\u00fcs","year":"2013","journal-title":"Fungal Biology Reviews"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0355","first-page":"186","article-title":"In silico methods for drug repurposing and pharmacology: Computational approaches to drug repurposing and pharmacology","volume":"8","author":"Hodos","year":"2016","journal-title":"Wiley Interdisciplinary Reviews: Systems Biology and Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005927","article-title":"Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection","volume":"11","author":"Holanda","year":"2017","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030024","article-title":"Essential Gene Identification and Drug Target Prioritization in Aspergillus fumigatus","volume":"3","author":"Hu","year":"2007","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0370","doi-asserted-by":"crossref","first-page":"e02334","DOI":"10.1128\/mBio.02334-14","article-title":"Essential Gene Discovery in the Basidiomycete Cryptococcus neoformans for Antifungal Drug Target Prioritization","volume":"6","author":"Ianiri","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0375","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00294-016-0659-2","article-title":"Isolation of conditional mutations in genes essential for viability of Cryptococcus neoformans","volume":"63","author":"Ianiri","year":"2017","journal-title":"Current Genetics"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0380","doi-asserted-by":"crossref","DOI":"10.1007\/s11274-017-2214-9","article-title":"\u03b1-Bisabolol inhibits Aspergillus fumigatus Af239 growth via affecting microsomal \u220624-sterol methyltransferase as a crucial enzyme in ergosterol biosynthesis pathway","volume":"33","author":"Jahanshiri","year":"2017","journal-title":"World Journal of Microbiology and Biotechnology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0385","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive interferon-\u03b3 immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial","volume":"26","author":"Jarvis","year":"2012","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.pharmthera.2018.10.008_bb0390","doi-asserted-by":"crossref","first-page":"E98","DOI":"10.3390\/jof4030098","article-title":"Treatment of Aspergillosis","volume":"4","author":"Jenks","year":"2018","journal-title":"Journal of Fungi (Basel)"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0395","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1128\/AAC.02145-13","article-title":"Enfumafungin Derivative MK-3118 Shows Increased In Vitro Potency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates","volume":"58","author":"Jim\u00e9nez-Ortigosa","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0400","article-title":"Essential Roles of the Kar2\/BiP Molecular Chaperone Downstream of the UPR Pathway in Cryptococcus neoformans","volume":"8","author":"Jung","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0405","doi-asserted-by":"crossref","first-page":"e00537","DOI":"10.1128\/mSphere.00537-17","article-title":"Novel Antifungal Compounds Discovered in Medicines for Malaria Venture\u2019s Malaria Box","volume":"3","author":"Jung","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0410","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1586\/14787210.2014.976613","article-title":"Antimicrobial peptides: therapeutic potentials","volume":"12","author":"Kang","year":"2014","journal-title":"Expert Review of Anti-infective Therapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0415","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/jam.12745","article-title":"Analysis of the essentiality of ROM2 genes in the pathogenic yeasts Candida glabrata and Candida albicans using temperature-sensitive mutants","volume":"118","author":"Kanno","year":"2015","journal-title":"Journal of Applied Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0420","series-title":"ECCMID 2017, Vienna, Austria","article-title":"Assessment of the duration of infusion on the tolerability and repeat dose pharmacokinetics of F901318 in healthy volunteers","author":"Kennedy","year":"2017"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0425","series-title":"Multiple dose pharmacokinetics of an immediate-release tablet formulation of F901318 in healthy male and female subjects","author":"Kennedy","year":"2017"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0430","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/jac\/dkh522","article-title":"Enhanced anticryptococcal activity of chloroquine in phosphatidylserine-containing liposomes in a murine model","volume":"55","author":"Khan","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0435","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/21505594.2015.1049807","article-title":"Histone deacetylases: Targets for antifungal drug development","volume":"6","author":"Kmetzsch","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0440","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1099\/mic.0.28571-0","article-title":"Calcineurin, Mpk1 and Hog1 MAPK pathways independently control fludioxonil antifungal sensitivity in Cryptococcus neoformans","volume":"152","author":"Kojima","year":"2006","journal-title":"Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0445","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/iub.1734","article-title":"Generating anchors only to lose them: The unusual story of glycosylphosphatidylinositol anchor biosynthesis and remodeling in yeast and fungi: GPI BIOSYNTHESIS IN YEAST AND FUNGI","volume":"70","author":"Komath","year":"2018","journal-title":"IUBMB Life"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0450","series-title":"Proteomics for Drug Discovery","first-page":"255","article-title":"Docking and Virtual Screening in Drug Discovery","author":"Kontoyianni","year":"2017"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0455","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1128\/AAC.01061-16","article-title":"The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis","volume":"60","author":"Koselny","year":"2016","journal-title":"Antimicrobial Agents Chemotherapy."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0460","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ardp.201300338","article-title":"Synthesis and Biological Evaluation of Novel N -Alkyl Tetra- and Decahydroisoquinolines: Novel Antifungals that Target Ergosterol Biosynthesis: Antifungal N -Alkyl Tetra- and Decahydroisoquinolines","volume":"347","author":"Krauss","year":"2014","journal-title":"Archiv der Pharmazie"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0465","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.peptides.2015.05.012","article-title":"Antimicrobial peptides: Possible anti-infective agents","volume":"72","author":"Lakshmaiah Narayana","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.00096","article-title":"Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis","volume":"6","author":"Lamoth","year":"2015","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0475","doi-asserted-by":"crossref","first-page":"e02396","DOI":"10.1128\/AAC.02396-16","article-title":"The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation","volume":"61","author":"Larkin","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0480","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/AAC.49.3.952-958.2005","article-title":"Phase I Evaluation of the Safety and Pharmacokinetics of Murine-Derived Anticryptococcal Antibody 18B7 in Subjects with Treated Cryptococcal Meningitis","volume":"49","author":"Larsen","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0485","doi-asserted-by":"crossref","first-page":"e00156","DOI":"10.1128\/AAC.00156-18","article-title":"Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids","volume":"62","author":"Lazzarini","year":"2018","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0490","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bmcl.2009.01.017","article-title":"5-Hydroxyindole-type alkaloids, as Candida albicans isocitrate lyase inhibitors, from the tropical sponge Hyrtios sp","volume":"19","author":"Lee","year":"2009","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0495","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/jm301501k","article-title":"Sulfonylureas Have Antifungal Activity and Are Potent Inhibitors of Candida albicans Acetohydroxyacid Synthase","volume":"56","author":"Lee","year":"2013","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0500","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1128\/AAC.04445-14","article-title":"Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), Using an In Vivo Murine Invasive Candidiasis Model","volume":"59","author":"Lepak","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0505","first-page":"e02154","article-title":"Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing Design","volume":"62","author":"Lepak","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0510","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3390\/molecules22112004","article-title":"Synthesis of Oxadiazole-Thiadiazole Hybrids and Their Anticandidal Activity","volume":"22","author":"Levent","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0515","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-immunol-042617-053318","article-title":"Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts","volume":"36","author":"Lionakis","year":"2018","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0520","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","article-title":"Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances","volume":"14","author":"Lionta","year":"2014","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0525","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/EC.5.4.638-649.2006","article-title":"Conserved Fungal Genes as Potential Targets for Broad-Spectrum Antifungal Drug Discovery","volume":"5","author":"Liu","year":"2006","journal-title":"Eukaryotic Cell"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0530","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.vaccine.2010.12.119","article-title":"Immune responses induced by heat killed Saccharomyces cerevisiae: A vaccine against fungal infection","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0535","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/EC.1.5.657-662.2002","article-title":"Life and Death in a Macrophage: Role of the Glyoxylate Cycle in Virulence","volume":"1","author":"Lorenz","year":"2002","journal-title":"Eukaryotic Cell"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0540","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/AAC.34.9.1660","article-title":"Effects of lovastatin (mevinolin) on sterol levels and on activity of azoles in Saccharomyces cerevisiae","volume":"34","author":"Lorenz","year":"1990","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0545","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1128\/AAC.01324-10","article-title":"Dose Range Evaluation of Mycograb C28Y Variant, a Human Recombinant Antibody Fragment to Heat Shock Protein 90, in Combination with Amphotericin B-Desoxycholate for Treatment of Murine Systemic Candidiasis","volume":"55","author":"Louie","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0550","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.compbiolchem.2014.01.011","article-title":"Predicting essential genes for identifying potential drug targets in Aspergillus fumigatus","volume":"50","author":"Lu","year":"2014","journal-title":"Computational Biology and Chemistry"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0555","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10096-008-0553-z","article-title":"Human antimicrobial peptides\u2019 antifungal activity against Aspergillus fumigatus","volume":"27","author":"Lupetti","year":"2008","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0560","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1200\/JCO.2009.25.8723","article-title":"Acute Myeloid Leukemia or Myelodysplastic Syndrome in Randomized Controlled Clinical Trials of Cancer Chemotherapy With Granulocyte Colony-Stimulating Factor: A Systematic Review","volume":"28","author":"Lyman","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0565","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/0300060515583708","article-title":"Effect of statins on preventing infectious complications after surgery: Systematic review and meta-analysis","volume":"43","author":"Ma","year":"2015","journal-title":"Journal of International Medical Research"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0570","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10822-014-9760-0","article-title":"Chemical space networks: a powerful new paradigm for the description of chemical space","volume":"28","author":"Maggiora","year":"2014","journal-title":"Journal of Computer-Aided Molecular Design"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0575","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial Peptides: An Emerging Category of Therapeutic Agents","volume":"6","author":"Mahlapuu","year":"2016","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0580","doi-asserted-by":"crossref","first-page":"32709","DOI":"10.1074\/jbc.272.51.32709","article-title":"Khafrefungin, a Novel Inhibitor of Sphingolipid Synthesis","volume":"272","author":"Mandala","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0585","doi-asserted-by":"crossref","first-page":"14942","DOI":"10.1074\/jbc.273.24.14942","article-title":"Rustmicin, a Potent Antifungal Agent, Inhibits Sphingolipid Synthesis at Inositol Phosphoceramide Synthase","volume":"273","author":"Mandala","year":"1998","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0590","series-title":"Small Wonders: Peptides for Disease Control","first-page":"337","article-title":"Antifungal Peptides: Exploiting Non-Lytic Mechanisms and Cell Penetration Properties","author":"Marcos","year":"2012"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0595","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/jac\/dkx010","article-title":"The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp","volume":"72","author":"Marcos-Zambrano","year":"2017","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0600","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1358\/dof.2010.35.3.1452077","article-title":"Peptide-based antifungal therapies against emerging infections","volume":"35","author":"Matejuk","year":"2010","journal-title":"Drugs of the Future"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0605","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/infdis\/171.6.1668","article-title":"Preliminary Assessment of a Human Recombinant Antibody Fragment to hsp90 in Murine Invasive Candidiasis","volume":"171","author":"Matthews","year":"1995","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0610","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1128\/AAC.47.7.2208-2216.2003","article-title":"Preclinical Assessment of the Efficacy of Mycograb, a Human Recombinant Antibody against Fungal HSP90","volume":"47","author":"Matthews","year":"2003","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0615","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00726-005-0297-3","article-title":"Acetohydroxyacid synthase and its role in the biosynthetic pathway for branched-chain amino acids","volume":"31","author":"McCourt","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0620","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1021\/cb300235m","article-title":"Inhibiting GPI Anchor Biosynthesis in Fungi Stresses the Endoplasmic Reticulum and Enhances Immunogenicity","volume":"7","author":"McLellan","year":"2012","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0625","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cbpa.2017.03.014","article-title":"Host defense antimicrobial peptides as antibiotics: design and application strategies","volume":"38","author":"Mishra","year":"2017","journal-title":"Current Opinion in Chemical Biology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0630","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/AAC.00291-11","article-title":"In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds","volume":"55","author":"Miyazaki","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0635","doi-asserted-by":"crossref","unstructured":"Mor, V., Rella, A., Farnoud, A.M., Singh, A., Munshi, M., Bryan, A., Naseem, S., Konopka, J.B., Ojima, I., Bullesbach, E., Ashbaugh, A., Linke, M.J., Cushion, M., Collins, M., Ananthula, H.K., Sallans, L., Desai, P.B., Wiederhold, N.P., Fothergill, A.W., Kirkpatrick, W.R., Patterson, T., Wong, L.H., Sinha, S., Giaever, G., Nislow, C., Flaherty, P., Pan, X., Cesar, G.V., de Melo Tavares, P., Frases, S., Miranda, K., Rodrigues, M.L., Luberto, C., Nimrichter, L., Del Poeta, M., 2015. Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids. mBio 6, e00647-15.","DOI":"10.1128\/mBio.00647-15"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0640","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1128\/IAI.71.9.5273-5279.2003","article-title":"A Monoclonal Antibody Directed against a Candida albicans Cell Wall Mannoprotein Exerts Three Anti-C. albicans Activities","volume":"71","author":"Moragues","year":"2003","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0650","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11046-014-9801-1","article-title":"Immunization with P10 Peptide Increases Specific Immunity and Protects Immunosuppressed BALB\/c Mice Infected with Virulent Yeasts of Paracoccidioides brasiliensis","volume":"178","author":"Mu\u00f1oz","year":"2014","journal-title":"Mycopathologia"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0655","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ja.2016.107","article-title":"ASP2397: a novel antifungal agent produced by Acremonium persicinum MF-347833","volume":"70","author":"Nakamura","year":"2017","journal-title":"The Journal of Antibiotics"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002771","article-title":"Tc17 Cells Mediate Vaccine Immunity against Lethal Fungal Pneumonia in Immune Deficient Hosts Lacking CD4+ T Cells","volume":"8","author":"Nanjappa","year":"2012","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0665","doi-asserted-by":"crossref","unstructured":"Neal, L.M., Xing, E., Xu, J., Kolbe, J.L., Osterholzer, J.J., Segal, B.M., Williamson, P.R., Olszewski, M.A., 2017. CD4 + T Cells Orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis. mBio 8, e01415-17.","DOI":"10.1128\/mBio.01415-17"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0670","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI117119","article-title":"Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis","volume":"93","author":"Newman","year":"1994","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0675","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.3402\/ehtj.v2i0.7078","article-title":"Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections","volume":"2","author":"Nijnik","year":"2009","journal-title":"Emerging Health Threats Journal"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0680","first-page":"e01909","article-title":"Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis","volume":"62","author":"Nixon","year":"2018","journal-title":"a Neglected Fungal Disease. Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0685","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI19361","article-title":"Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum","volume":"112","author":"Nosanchuk","year":"2003","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0690","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1128\/AAC.02810-15","article-title":"Repurposing of Aspirin and Ibuprofen as Candidate Anti-Cryptococcus Drugs","volume":"60","author":"Ogundeji","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0695","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1073\/pnas.1608304113","article-title":"F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase","volume":"113","author":"Oliver","year":"2016","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0700","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1128\/AAC.00701-16","article-title":"Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin","volume":"60","author":"Ong","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0705","doi-asserted-by":"crossref","first-page":"e01626","DOI":"10.1128\/AAC.01626-16","article-title":"Pharmacokinetics of the Novel Echinocandin CD101 in Multiple Animal Species","volume":"61","author":"Ong","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0710","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.44.2.368-377.2000","article-title":"Discovery of Novel Antifungal (1,3)-beta -D-Glucan Synthase Inhibitors","volume":"44","author":"Onishi","year":"2000","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0715","doi-asserted-by":"crossref","first-page":"7472","DOI":"10.1016\/S0021-9258(18)68522-9","article-title":"Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans","volume":"263","author":"Oppenheim","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0720","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1208\/s12248-012-9390-1","article-title":"Drug Repurposing: Far Beyond New Targets for Old Drugs","volume":"14","author":"Oprea","year":"2012","journal-title":"The AAPS Journal"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0725","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/503428","article-title":"A Randomized, Blinded, Multicenter Trial of Lipid-Associated Amphotericin B Alone versus in Combination with an Antibody-Based Inhibitor of Heat Shock Protein 90 in Patients with Invasive Candidiasis","volume":"42","author":"Pachl","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0730","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/07388551.2011.594423","article-title":"Antimicrobial peptides: key components of the innate immune system","volume":"32","author":"Pasupuleti","year":"2012","journal-title":"Critical Reviews in Biotechnology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0735","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1128\/JCM.00618-09","article-title":"Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens","volume":"47","author":"Pfaller","year":"2009","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0740","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/AAC.01588-12","article-title":"In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods","volume":"57","author":"Pfaller","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0745","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/jac\/dks466","article-title":"Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)","volume":"68","author":"Pfaller","year":"2013","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0750","article-title":"Repurposing the anthelminthic salicylanilide oxyclozanide against susceptible and clinical resistant Candida albicans strains","author":"Pic","year":"2018","journal-title":"Medical Mycology."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0755","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jac\/dki264","article-title":"Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry","volume":"56","author":"Pina-Vaz","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0760","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1016\/S0264-410X(00)00074-8","article-title":"DNA-based vaccination against murine paracoccidioidomycosis using the gp43 gene from Paracoccidioides brasiliensis","volume":"18","author":"Pinto","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0765","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2174\/092986612803521620","article-title":"Identification of a Novel Antifungal Peptide with Chitin-Binding Property from Marine Metagenome","volume":"19","author":"Pushpanathan","year":"2012","journal-title":"Protein & Peptide Letters"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0770","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00278-07","article-title":"An Anti- -Glucan Monoclonal Antibody Inhibits Growth and Capsule Formation of Cryptococcus neoformans In Vitro and Exerts Therapeutic, Anticryptococcal Activity In Vivo","volume":"75","author":"Rachini","year":"2007","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0775","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1007\/s00253-014-5719-2","article-title":"Inhibition of Candida albicans virulence factors by novel levofloxacin derivatives","volume":"98","author":"Raja Mohamed","year":"2014","journal-title":"Applied Microbiology and Biotechnology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0780","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S1473-3099(16)00074-8","article-title":"Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study","volume":"16","author":"Rhein","year":"2016","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0785","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.vaccine.2008.10.022","article-title":"DNAhsp65 vaccination induces protection in mice against Paracoccidioides brasiliensis infection","volume":"27","author":"Ribeiro","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0790","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.vaccine.2009.11.062","article-title":"HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis","volume":"28","author":"Ribeiro","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0795","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijantimicag.2017.04.005","article-title":"Atorvastatin as a promising anticryptococcal agent","volume":"49","author":"Ribeiro","year":"2017","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0800","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1128\/AAC.01809-12","article-title":"Identification and Evaluation of Novel Acetolactate Synthase Inhibitors as Antifungal Agents","volume":"57","author":"Richie","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001519","article-title":"Therapeutic DNA Vaccine Encoding Peptide P10 against Experimental Paracoccidioidomycosis","volume":"6","author":"Rittner","year":"2012","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0810","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.celrep.2015.10.018","article-title":"An Antifungal Combination Matrix Identifies a Rich Pool of Adjuvant Molecules that Enhance Drug Activity against Diverse Fungal Pathogens","volume":"13","author":"Robbins","year":"2015","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0815","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2958.2003.03697.x","article-title":"Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery: C. albicans essential gene identification and antifungal drug discovery","volume":"50","author":"Roemer","year":"2003","journal-title":"Molecular Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0820","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1128\/IAI.68.5.2845-2853.2000","article-title":"Synthesis of Polymerized Melanin by Cryptococcus neoformans in Infected Rodents","volume":"68","author":"Rosas","year":"2000","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0825","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1128\/IAI.69.5.3410-3412.2001","article-title":"Passive Immunization with Melanin-Binding Monoclonal Antibodies Prolongs Survival of Mice with Lethal Cryptococcus neoformans Infection","volume":"69","author":"Rosas","year":"2001","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0830","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.bmc.2016.01.026","article-title":"In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp","volume":"24","author":"Rosato","year":"2016","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0835","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1568005033342064","article-title":"Chitin Synthesis as a Target for Antifungal Drugs","volume":"3","author":"Ruiz-Herrera","year":"2003","journal-title":"Current Drug Target -Infectious Disorders"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0840","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2217\/fmb-2017-0065","article-title":"A new small-molecule KRE2 inhibitor against invasive Candida parapsilosis infection","volume":"12","author":"Salci","year":"2017","journal-title":"Future Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0845","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1128\/iai.58.6.1919-1923.1990","article-title":"Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide","volume":"58","author":"Sanford","year":"1990","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0850","doi-asserted-by":"crossref","first-page":"e01102","DOI":"10.1128\/AAC.01102-17","article-title":"Antifungal Activity of SCY-078 and Standard Antifungal Agents against 178 Clinical Isolates of Resistant and Susceptible Candida Species","volume":"61","author":"Schell","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0855","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/iai.58.6.1914-1918.1990","article-title":"Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide","volume":"58","author":"Schlageter","year":"1990","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0860","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0865","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1128\/IAI.74.5.3042-3045.2006","article-title":"A Fungicidal Monoclonal Antibody Protects against Murine Invasive Candidiasis","volume":"74","author":"Sevilla","year":"2006","journal-title":"Infection and Immunity"},{"issue":"1","key":"10.1016\/j.pharmthera.2018.10.008_bb0870","first-page":"DC20","article-title":"Ibuprofen-Mediated Reversal of Fluconazole Resistance in Clinical Isolates of Candida","volume":"9","author":"Sharma","year":"2015","journal-title":"Journal of Clinical and Diagnostic Research"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0875","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2323\/jgam.59.167","article-title":"An in vitro repositioning study reveals antifungal potential of chloroquine to inhibit growth and morphogenesis in Candida albicans","volume":"59","author":"Shinde","year":"2013","journal-title":"The Journal of General and Applied Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0880","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/infdis\/jiu029","article-title":"Modeling Nikkomycin Z Dosing and Pharmacology in Murine Pulmonary Coccidioidomycosis Preparatory to Phase 2 Clinical Trials","volume":"209","author":"Shubitz","year":"2014","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0885","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1574-6968.2011.02386.x","article-title":"Effects of microplusin, a copper-chelating antimicrobial peptide, against Cryptococcus neoformans","volume":"324","author":"Silva","year":"2011","journal-title":"FEMS Microbiology Letters"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0890","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.01057","article-title":"Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis","volume":"8","author":"Silva","year":"2017","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmgm.2015.10.014","article-title":"In silico and in vitro screening to identify structurally diverse non-azole CYP51 inhibitors as potent antifungal agent","volume":"63","author":"Singh","year":"2016","journal-title":"Journal of Molecular Graphics and Modelling"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0900","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11046-012-9599-7","article-title":"DNA-hsp65 Vaccine as Therapeutic Strategy to Treat Experimental Chromoblastomycosis Caused by Fonsecaea Pedrosoi","volume":"175","author":"Siqueira","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0905","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jgar.2018.02.013","article-title":"Rezafungin (CD101), a next generation echinocandin. A systematic literature review and assessment of possible place in therapy","volume":"14","author":"Sofjan","year":"2018","journal-title":"Journal of Global Antimicrobial Resistance."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0910","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3109\/1040841X.2015.1068271","article-title":"Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes","volume":"42","author":"Song","year":"2016","journal-title":"Critical Reviews in Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0915","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4065\/mcp.2010.0447","article-title":"Statin Therapy and Decreased Incidence of Positive Candida Cultures Among Patients With Type 2 Diabetes Mellitus Undergoing Gastrointestinal Surgery","volume":"85","author":"Spanakis","year":"2010","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0920","doi-asserted-by":"crossref","unstructured":"Specht, C.A., Lee, C.K., Huang, H., Tipper, D.J., Shen, Z.T., Lodge, J.K., Leszyk, J., Ostroff, G.R., Levitz, S.M., 2015. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts. mBio 6, e01905-15.","DOI":"10.1128\/mBio.01905-15"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0925","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/msb.2011.31","article-title":"Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole","volume":"7","author":"Spitzer","year":"2014","journal-title":"Molecular Systems Biology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0930","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/ijms18010177","article-title":"Design, Synthesis and Antifungal Activity Evaluation of New Thiazolin-4-ones as Potential Lanosterol 14\u03b1-Demethylase Inhibitors","volume":"18","author":"Stana","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0935","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.imbio.2010.07.003","article-title":"Host defense peptides and their antimicrobial-immunomodulatory duality","volume":"216","author":"Steinstraesser","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0940","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1345\/aph.1M237","article-title":"Echinocandins: The Newest Class of Antifungals","volume":"43","author":"Sucher","year":"2009","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0945","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1568005043340597","article-title":"IPC Synthase as a Useful Target for Antifungal Drugs","volume":"4","author":"Sugimoto","year":"2004","journal-title":"Current Drug Target -Infectious Disorders"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0950","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17147-x","article-title":"Repurposing an inhibitor of ribosomal biogenesis with broad anti-fungal activity","volume":"7","author":"Sun","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0955","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.1039\/C5OB00693G","article-title":"One-pot three-component domino protocol for the synthesis of novel pyrano[2,3-d]pyrimidines as antimicrobial and anti-biofilm agents","volume":"13","author":"Suresh","year":"2015","journal-title":"Organic & Biomolecular Chemistry"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0960","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1128\/IAI.66.2.786-793.1998","article-title":"Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis, which induces a Th-1 response protective against fungal infection in BALB\/c mice","volume":"66","author":"Taborda","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0965","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.7164\/antibiotics.46.1414","article-title":"Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic","volume":"46","author":"Takesako","year":"1993","journal-title":"The Journal of Antibiotics"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0970","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/138920208784139537","article-title":"Linking Fold, Function and Phylogeny: A Comparative Genomics View on Protein (Domain) Evolution","volume":"9","author":"te Velthuis","year":"2008","journal-title":"Current Genomics"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0975","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2017.00004","article-title":"Repurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 Pathway","volume":"7","author":"Thangamani","year":"2017","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0980","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/molecules22071172","article-title":"Facile Synthesis of Novel Coumarin Derivatives, Antimicrobial Analysis, Enzyme Assay, Docking Study, ADMET Prediction and Toxicity Study","volume":"22","author":"Tiwari","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0985","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20050749","article-title":"A novel glyco-conjugate vaccine against fungal pathogens","volume":"202","author":"Torosantucci","year":"2005","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0990","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/mmy\/myv109","article-title":"Activity of sertraline against Cryptococcus neoformans\u202f: in vitro and in vivo assays","volume":"54","author":"Trevi\u00f1o-Rangel","year":"2016","journal-title":"Medical Mycology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb0995","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.compbiolchem.2017.12.013","article-title":"Identification of potential inhibitors against nuclear Dam1 complex subunit Ask1 of Candida albicans using virtual screening and MD simulations","volume":"72","author":"Tripathi","year":"2018","journal-title":"Computational Biology and Chemistry"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1000","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4761","article-title":"Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis","volume":"6","author":"Truong","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0304-4165(97)00076-7","article-title":"Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans","volume":"1336","author":"Tsai","year":"1997","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00024382-200201000-00005","article-title":"Effect Of In vivo Infusion of Granulocyte Colony-Stimulating Factor on Immune Function","volume":"17","author":"Valente","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1015","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.steroids.2011.04.012","article-title":"Synthesis, in vitro antifungal activity and mechanism of action of four sterol hydrazone analogues against the dimorphic fungus Paracoccidioides brasiliensis","volume":"76","author":"Visbal","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/AAC.00478-06","article-title":"Human-Defensins Kill Candida albicans in an Energy-Dependent and Salt-Sensitive Manner without Causing Membrane Disruption","volume":"51","author":"Vylkova","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1025","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2014.60.5121","article-title":"Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial","volume":"33","author":"Wan","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1030","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1016\/j.bmc.2015.06.053","article-title":"Imidazole clubbed 1,3,4-oxadiazole derivatives as potential antifungal agents","volume":"23","author":"Wani","year":"2015","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijantimicag.2017.09.002","article-title":"The antifungal arsenal: alternative drugs and future targets","volume":"51","author":"Wiederhold","year":"2018","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1040","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1128\/AAC.03944-14","article-title":"The Investigational Agent E1210 Is Effective in Treatment of Experimental Invasive Candidiasis Caused by Resistant Candida albicans","volume":"59","author":"Wiederhold","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1045","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/jac\/dkx422","article-title":"Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata","volume":"73","author":"Wiederhold","year":"2018","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1050","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.00274-06","article-title":"Protection against Cryptococcosis by Using a Murine Gamma Interferon-Producing Cryptococcus neoformans Strain","volume":"75","author":"Wormley","year":"2007","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1055","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/cmdc.201402320","article-title":"From Antidiabetic to Antifungal: Discovery of Highly Potent Triazole-Thiazolidinedione Hybrids as Novel Antifungal Agents","volume":"9","author":"Wu","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1060","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20030109","article-title":"Vaccine Immunity to Pathogenic Fungi Overcomes the Requirement for CD4 Help in Exogenous Antigen Presentation to CD8 + T Cells: Implications for Vaccine Development in Immune-deficient Hosts","volume":"197","author":"W\u00fcthrich","year":"2003","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1065","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/acsmedchemlett.5b00029","article-title":"Generation of Broad-Spectrum Antifungal Drug Candidates from the Natural Product Compound Aureobasidin A","volume":"6","author":"Wuts","year":"2015","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1070","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1099\/mic.0.045054-0","article-title":"Glutathione biosynthesis in the yeast pathogens Candida glabrata and Candida albicans: essential in C. glabrata, and essential for virulence in C. albicans","volume":"157","author":"Yadav","year":"2011","journal-title":"Microbiology"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012171","article-title":"HOS2 and HDA1 Encode Histone Deacetylases with Opposing Roles in Candida albicans Morphogenesis","volume":"5","author":"Zacchi","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1080","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1073\/pnas.84.15.5449","article-title":"Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor","volume":"84","author":"Zasloff","year":"1987","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1085","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.00212-12","article-title":"The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections","volume":"56","author":"Zhai","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1090","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1080\/00397911.2014.935436","article-title":"Microwave-Assisted Synthesis and Antifungal Activities of Polysubstituted Furo[3,2-c]chromen-4-ones and 7,8,9,10-Tetrahydro-6 H -benzofuro[3,2-c]chromen-6-ones","volume":"44","author":"Zhang","year":"2014","journal-title":"Synthetic Communications"},{"key":"10.1016\/j.pharmthera.2018.10.008_bb1095","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ejmech.2016.07.067","article-title":"Design, synthesis, and structure-activity relationship studies of benzothiazole derivatives as antifungal agents","volume":"123","author":"Zhao","year":"2016","journal-title":"European Journal of Medicinal Chemistry"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372581830192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372581830192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:55:23Z","timestamp":1759010123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372581830192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":218,"alternative-id":["S016372581830192X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2018.10.008","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal drugs: New insights in research & development","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}